Protection against oxidant-mediated lysosomal rupture: a new anti-apoptotic activity of Bcl-2?

被引:81
|
作者
Zhao, M
Eaton, JW
Brunk, UT [1 ]
机构
[1] Linkoping Univ, Fac Hlth Sci, Div Pathol 2, SE-58185 Linkoping, Sweden
[2] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
关键词
lysosome stability; Bcl-2; oxidative stress; apoptosis;
D O I
10.1016/S0014-5793(00)02195-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bcl-2 antagonizes apoptosis through mechanisms which are not completely understood. We have proposed that apoptosis is initiated by minor lysosomal destabilization followed some time later by secondary massive lysosomal rupture. In J774 cells over-expressing Bcl-2, early oxidant-induced lysosomal destabilization is unaffected but secondary lysosomal rupture and apoptosis are suppressed, despite the fact that wild-type and Bcl-2 over-expressing cells degrade hydrogen peroxide at similar rates. It may be that Bcl-2 directly blocks the effects of released lysosomal enzymes and/or prevents downstream activation of unknown cytosolic pro-enzymes by released lysosomal hydrolases, suggesting a new and heretofore unknown activity of Bcl-2, (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:104 / 108
页数:5
相关论文
共 50 条
  • [31] The cellular concentration of Bcl-2 determines its pro- or anti-apoptotic effect
    Hanson, C. Jane
    Bootman, Martin D.
    Distelhorst, Clark W.
    Maraldi, Tullia
    Roderick, H. Llewelyn
    CELL CALCIUM, 2008, 44 (03) : 243 - 258
  • [32] Peptide screening to knockdown Bcl-2's anti-apoptotic activity: Implications in cancer treatment
    Raghav, Pawan Kumar
    Verma, Yogesh Kumar
    Gangenahalli, Gurudutta U.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2012, 50 (03) : 796 - 814
  • [33] Pomolic acid may overcome multidrug resistance mediated by overexpression of anti-apoptotic Bcl-2 proteins
    Fernandes, Janaina
    Weinlich, Ricardo
    Castilho, Rachel Oliveira
    Amarante-Mendes, Gustavo Pessini
    Gattass, Cerli Rocha
    CANCER LETTERS, 2007, 245 (1-2) : 315 - 320
  • [34] Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: New avenues for cancer chemoprevention and chemotherapy
    Pellecchia, M
    Reed, JC
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (12) : 1387 - 1398
  • [35] Pro- and anti-apoptotic members of the Bcl-2 family in skeletal muscle: A distinct role for Bcl-2 in later stages of myogenesis
    Dominov, JA
    Houlihan-Kamamoto, CA
    Swap, CJ
    Miller, JB
    DEVELOPMENTAL DYNAMICS, 2001, 220 (01) : 18 - 26
  • [36] Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context
    Md. Saddam
    Shamrat Kumar Paul
    Mohammad Ahsan Habib
    Md. Abrar Fahim
    Afsana Mimi
    Saiful Islam
    Bristi Paul
    Md Mostofa Uddin Helal
    Egyptian Journal of Medical Human Genetics, 25
  • [37] Patent landscape of inhibitors and PROTACs of the anti-apoptotic BCL-2 family proteins
    Pal, Pratik
    Zhang, Peiyi
    Poddar, Saikat K.
    Zheng, Guangrong
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (09) : 1003 - 1026
  • [38] Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
    Bulanova, Daria
    Ianevski, Aleksandr
    Bugai, Andrii
    Akimov, Yevhen
    Kuivanen, Suvi
    Paavilainen, Henrik
    Kakkola, Laura
    Nandania, Jatin
    Turunen, Laura
    Ohman, Tiina
    Ala-Hongisto, Hanna
    Pesonen, Hanna M.
    Kuisma, Marika S.
    Honkimaa, Anni
    Walton, Emma L.
    Oksenych, Valentyn
    Lorey, Martina B.
    Guschin, Dmitry
    Shim, Jungmin
    Kim, Jinhee
    Than, Thoa T.
    Chang, So Young
    Hukkanen, Veijo
    Kulesskiy, Evgeny
    Marjomaki, Varpu S.
    Julkunen, Ilkka
    Nyman, Tuula A.
    Matikainen, Sampsa
    Saarela, Jani S.
    Sane, Famara
    Hober, Didier
    Gabriel, Guelsah
    De Brabander, Jef K.
    Martikainen, Miika
    Windisch, Marc P.
    Min, Ji-Young
    Bruzzone, Roberto
    Aittokallio, Tero
    Vaha-Koskela, Markus
    Vapalahti, Olli
    Pulk, Arto
    Velagapudi, Vidya
    Kainov, Denis E.
    VIRUSES-BASEL, 2017, 9 (10):
  • [39] Interaction studies to evaluate 2- carboxyphenolate analogues as inhibitor of anti-apoptotic protein Bcl-2
    Al-Karaawi, Mohammed A.
    BIOINFORMATION, 2013, 9 (09) : 477 - 480
  • [40] Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation
    Robinson, Blaine W.
    Behling, Kathryn C.
    Gupta, Manish
    Zhang, Alena Y.
    Moore, Jonni S.
    Bantly, Andrew D.
    Willman, Cheryl L.
    Carroll, Andrew J.
    Adamson, Peter C.
    Barrett, Jeffrey S.
    Felix, Carolyn A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (06) : 827 - 839